Richard S. Serbin's Insider Trades & SAST Disclosures
Richard S. Serbin's most recent trade in Co-Diagnostics Inc was a trade of 48,333 Common Stock done . Disclosure was reported to the exchange on Nov. 25, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Richard S. Serbin.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Co-Diagnostics Inc | Richard S. Serbin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Nov 2024 | 48,333 | 165,833 (0%) | 0% | 0 | Common Stock | |
| Co-Diagnostics Inc | Richard S. Serbin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Nov 2024 | 48,333 | 151,667 | - | - | Restricted Stock Unit | |
| Co-Diagnostics Inc | Richard S. Serbin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 May 2024 | 30,000 | 200,000 | - | - | Restricted Stock Unit | |
| Co-Diagnostics Inc | Richard S. Serbin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2024 | 30,000 | 117,500 (0%) | 0% | 0 | Common Stock | |
| Co-Diagnostics Inc | Richard S. Serbin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Apr 2024 | 110,000 | 230,000 | - | - | Restricted Stock Units | |
| Co-Diagnostics Inc | Richard S. Serbin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2023 | 70,000 | 150,000 | - | - | Restricted Stock Units | |
| Co-Diagnostics Inc | Richard S. Serbin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2023 | 18,333 | 57,500 (0%) | 0% | 0 | Common Stock | |
| Co-Diagnostics Inc | Richard S. Serbin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 May 2023 | 18,333 | 80,000 | - | - | Restricted Stock Units | |
| Co-Diagnostics Inc | Richard S. Serbin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 40,000 | 98,333 | - | - | Restricted Stock Units | |
| Co-Diagnostics Inc | Richard S. Serbin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jan 2023 | 12,500 | 58,333 | - | - | Restricted Stock Units | |
| Co-Diagnostics Inc | Richard S. Serbin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jan 2023 | 12,500 | 39,167 (0%) | 0% | 0 | Common Stock | |
| Co-Diagnostics Inc | Richard S. Serbin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Nov 2022 | 11,667 | 26,667 (0%) | 0% | 0 | Common Stock | |
| Co-Diagnostics Inc | Richard S. Serbin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Nov 2022 | 11,667 | 70,833 | - | - | Restricted Stock Units | |
| Co-Diagnostics Inc | Richard S. Serbin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jul 2022 | 70,000 | 82,500 | - | - | Restricted Stock Units | |
| Co-Diagnostics Inc | Richard S. Serbin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jan 2022 | 12,500 | 12,500 | - | - | Restricted Stock Units | |
| Co-Diagnostics Inc | Richard S. Serbin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jan 2022 | 12,500 | 15,000 (0%) | 0% | 0 | Common Stock | |
| Co-Diagnostics Inc | Richard S. Serbin | Director | Sale of securities on an exchange or to another person at price $ 10.29 per share. | 14 Jan 2021 | 10,000 | 2,500 (0%) | 0% | 10.3 | 102,900 | Common Stock |
| Co-Diagnostics Inc | Richard S. Serbin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2021 | 37,500 | 37,500 | - | - | Restricted Stock Units | |
| Co-Diagnostics Inc | Richard S. Serbin | Director | Sale of securities on an exchange or to another person at price $ 10.10 per share. | 14 Dec 2020 | 17,000 | 0 (0%) | 0% | 10.1 | 171,700 | Common Stock |
| Co-Diagnostics Inc | Richard S. Serbin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Nov 2020 | 17,000 | 17,000 | - | - | Restricted Stock Units | |
| Co-Diagnostics Inc | Richard S. Serbin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Nov 2020 | 17,000 | 0 | - | - | Restricted Stock Units | |
| Co-Diagnostics Inc | Richard S. Serbin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Nov 2020 | 17,000 | 17,000 (0%) | 0% | - | Common Stock | |
| Co-Diagnostics Inc | Richard S. Serbin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 May 2020 | 25,000 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Co-Diagnostics Inc | Richard S. Serbin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.96 per share. | 28 May 2020 | 25,000 | 25,000 (0%) | 0% | 4.0 | 99,000 | Common Stock |
| Co-Diagnostics Inc | Richard S. Serbin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.71 per share. | 19 May 2020 | 25,000 | 25,000 (0%) | 0% | 0.7 | 17,750 | Common Stock |
| Co-Diagnostics Inc | Richard S. Serbin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 May 2020 | 25,000 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Co-Diagnostics Inc | Richard S. Serbin | Director | Sale of securities on an exchange or to another person at price $ 18.50 per share. | 19 May 2020 | 25,000 | 0 (0%) | 0% | 18.5 | 462,500 | Common Stock |
| Co-Diagnostics Inc | Richard S. Serbin | Director | Sale of securities on an exchange or to another person at price $ 18.03 per share. | 19 May 2020 | 17,500 | 0 (0%) | 0% | 18.0 | 315,525 | Common Stock |
| Co-Diagnostics Inc | Richard S. Serbin | Director | Sale of securities on an exchange or to another person at price $ 18.00 per share. | 19 May 2020 | 7,500 | 0 (0%) | 0% | 18 | 135,000 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges